Adenovirus Vaccine Pregnancy Registry

Status Withdrawn

Clinical Trial Summary

The primary purpose of the Adenovirus Vaccine Pregnancy Registry is to prospectively collect data concerning:

1. Pregnant women exposed to Adenovirus Type 4 and Type 7 Vaccine, Live, Oral,

2. Potential confounding factors, and

3. The outcome of these pregnancies.

The secondary purpose of the Adenovirus Vaccine Pregnancy Registry is to evaluate the frequency of birth defects in prospectively enrolled pregnant women. This Registry is also designed to detect any unusual patterns of birth defects.

Clinical Trial Description

n/a

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01584037
Study type	Observational [Patient Registry]
Source	Teva Pharmaceutical Industries
Contact
Status	Withdrawn
Phase	N/A
Start date	December 2011
Completion date	April 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02984280` - Specific Respiratory Infections as Triggers of Acute Medical Events	N/A
Recruiting	`NCT03665675` - Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT	Early Phase 1
Completed	`NCT01431326` - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Recruiting	`NCT03266627` - Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection	Phase 2
Not yet recruiting	`NCT03325517` - Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics	N/A
Not yet recruiting	`NCT06392451` - LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia	N/A
Recruiting	`NCT05183490` - R-MVST Cells for Treatment of Viral Infections	Phase 1
Completed	`NCT04056546` - Interest of Rapid Typing in Adenovirus Infections.
Withdrawn	`NCT00448994` - Adenovirus and Fungal Load in Pediatric Stem Cell Transplant Patients	N/A
Recruiting	`NCT06299813` - Effectiveness of a Single Dose of Betamethasone in Children With Symptomatic Adenovirus Infection	Phase 3
Enrolling by invitation	`NCT06027879` - Anti-viral T-cell Therapy by Gamma Capture	Phase 1/Phase 2
Recruiting	`NCT02779439` - Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation	Phase 1
Terminated	`NCT02420080` - A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304	N/A
Active, not recruiting	`NCT01945814` - Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL)	Phase 1
Completed	`NCT01535885` - Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV	Phase 1
Terminated	`NCT03339401` - The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation	Phase 2
Withdrawn	`NCT03532035` - Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia	Phase 2
Recruiting	`NCT02008812` - Ad Sensor-based Real-time Diagnosis of Adenovirus	N/A
Active, not recruiting	`NCT04364178` - Viral Specific T-Lymphocytes to Treat Adenovirus or CMV	Phase 1/Phase 2
Recruiting	`NCT05664126` - Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation	Phase 2